Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $69.53 | $30.91 | 124.96% | 55.18x | 60.59x | 10.11x | 11.52x | 1.13x | $180.28M | 2.49% | $635.79M | 6.11 | $7.23B | 70.77 | ||
| TGTX | TG THERAPEUTICS INC | $31.75 | $14.57 | 117.91% | 77.44x | 41.33x | 10.26x | 18.22x | 0.99x | -$59.24M | -1.27% | $276.43M | 1.88 | $5.16B | 52.91 | ||
| CRMD | CORMEDIX INC | $12.65 | $12.43 | 1.81% | 48.65x | 8.32x | 10.00x | 7.47x | 0.44x | -$13.63M | -1.65% | $114.89M | 1.76 | $792.17M | 44.84 | ||
| HALO | HALOZYME THERAPEUTICS INC | $76.33 | $68.44 | 11.53% | 17.04x | 13.05x | 7.86x | 26.83x | 0.69x | $540.69M | 5.84% | $332.75M | 2.74 | $10.38B | 13.10 | ||
| KRYS | KRYSTAL BIOTECH INC | $155.71 | $93.62 | 66.32% | 30.47x | 32.95x | 12.53x | 4.33x | 0.93x | $185.88M | 4.13% | $1.04B | 36.00 | $4.16B | 23.78 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $36.56 | $5.57 | 556.60% | 609.33x | 35.50x | 5.07x | 5.47x | 2.66x | $66.49M | 2.48% | $495.01M | 6.74 | $2.53B | 132.70 | ||
| VCEL | VERICEL CORP | $31.42 | $5.41 | 480.62% | 224.43x | 159.74x | 6.35x | 5.17x | 2.60x | -$8.30M | -0.53% | $306.81M | 6.09 | $1.60B | 72.74 | ||
| RPRX | ROYALTY PHARMA PLC | $35.15 | $51.98 | -32.37% | 15.22x | 7.71x | 6.46x | 2.16x | 0.35x | $2.11B | 14.19% | $9.50B | 22.44 | $27.87B | 21.66 | ||
| ARGX | ARGENX SE | $756.83 | $216.28 | 249.93% | 30.24x | 46.89x | 24,413.87x | 6.44x | 4.25x | $467.72M | 1.01% | $7.17B | 117.50 | $43.79B | 53.97 | ||
| INVA | INNOVIVA INC | $19.55 | $17.56 | 11.32% | 32.05x | 9.87x | 3.32x | 1.72x | 0.53x | $196.35M | 15.97% | $714.82M | 11.37 | $1.28B | 10.23 | ||
| EXEL | EXELIXIS INC | $39.01 | $30.36 | 28.50% | 18.14x | 16.67x | 4.77x | 5.16x | 0.84x | $754.07M | 7.09% | $2.03B | 7.46 | $10.52B | 12.65 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.90 | $0.41 | 1,803.75% | 197.50x | 60.77x | 6.89x | 8.27x | 16.91x | $73.00k | 0.01% | $92.03M | 1.03 | $725.78M | 73.62 | ||
| ADMA | ADMA BIOLOGICS INC | $15.30 | $9.77 | 56.61% | 17.39x | 24.29x | 7.79x | 9.17x | 1.28x | $65.77M | 1.78% | $398.33M | 1.65 | $3.64B | 22.29 | ||
| INCY | INCYTE CORP | $83.14 | $63.21 | 31.53% | 18.81x | 16.31x | 3.52x | 3.89x | 0.85x | $958.08M | 5.94% | $4.17B | 21.50 | $14.31B | 10.56 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $32.50 | $37.14 | -12.49% | 10.28x | 10.31x | 2.42x | 2.42x | 0.67x | $258.73M | 13.85% | $773.08M | 13.45 | $1.50B | 5.64 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $12.81 | $5.61 | 128.30% | 29.11x | 19.89x | 6.64x | 5.03x | 1.62x | $92.38M | 5.35% | $335.30M | 2.49 | $1.72B | 19.83 | ||
| MDXG | MIMEDX GROUP INC | $6.97 | $4.87 | 43.24% | 31.68x | 24.46x | 2.83x | 4.76x | 0.74x | $57.13M | 5.55% | $216.62M | 1.47 | $930.87M | 17.12 | ||
| ATRA | ATARA BIOTHERAPEUTICS INC | $11.94 | $11.13 | 7.25% | 16.36x | -13.42x | 0.77x | -2.39x | 0.67x | -$63.66M | -43.71% | -$35.04M | -2.87 | $122.60M | 4.93 | ||
| TECH | BIO-TECHNE CORP | $51.62 | $19.86 | 159.88% | 109.83x | 29.29x | 6.67x | 4.18x | 1.15x | $256.55M | 3.16% | $1.92B | 12.18 | $8.31B | 38.32 | ||
| VCYT | VERACYTE INC | $31.87 | $9.82 | 224.65% | 74.12x | 36.95x | 5.37x | 2.09x | 1.66x | $78.45M | 3.15% | $1.19B | 15.31 | $2.36B | 37.42 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $53.14 | $44.15 | 20.37% | 15.45x | 14.28x | 3.33x | 1.69x | 0.85x | $694.91M | 6.81% | $6.03B | 31.41 | $9.59B | 10.26 | ||
| GMAB | GENMAB A | $27.99 | $18.45 | 51.71% | 14.20x | 16.60x | 5.41x | 3.39x | 1.58x | $938.44M | 5.23% | $5.30B | 8.26 | $16.79B | 9.24 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $19.76 | $19.10 | 3.47% | 11.42x | 9.02x | 4.32x | 2.83x | 0.85x | $274.72M | 11.38% | $856.03M | 7.01 | $1.77B | 5.70 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $9.68 | $1.38 | 603.24% | 42.09x | 76.40x | 6.59x | 12.03x | 411.48x | $20.95M | 2.73% | $64.20M | 0.81 | $714.83M | 36.14 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $393.21 | $141.07 | 178.74% | 27.85x | 24.76x | 8.84x | 5.87x | 2.61x | $3.50B | 3.47% | $17.18B | 66.91 | $97.37B | 21.21 | ||
| NVO | NOVO NORDISK A S | $55.62 | $30.62 | 81.65% | 14.28x | 14.46x | 5.10x | 9.47x | 2.83x | $10.18B | 4.10% | $26.22B | 5.87 | $260.95B | 10.67 | ||
| MNKD | MANNKIND CORP | $5.38 | $1.00 | 436.28% | 48.91x | 59.78x | 5.44x | -29.99x | 5.84x | $28.79M | 1.75% | -$55.04M | -0.18 | $1.88B | 23.78 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.